Progesterone Timing in PCOS
In women with PCOS who are not attempting to conceive and require endometrial protection, progesterone should be administered for 12-14 days every 28 days (typically cycle days 14-27 or the last 12-14 days of each month). This cyclical regimen provides adequate endometrial protection while inducing regular withdrawal bleeding.
Dosing Regimens
The standard approach for progesterone administration in PCOS follows these protocols:
Oral Micronized Progesterone (First Choice)
- Dose: 200 mg daily (or 300 mg at bedtime for better tolerability)
- Timing: Days 14-27 of a 28-day cycle, or for 12-14 consecutive days each month
- Rationale: Micronized progesterone has the most favorable safety profile with lower cardiovascular and thrombotic risk 1
Alternative Progestins (If Micronized Progesterone Unavailable)
- Medroxyprogesterone acetate (MPA): 10 mg daily for 12-14 days per month 1
- Dydrogesterone: 10 mg daily for 12-14 days per month 1
Clinical Context and Rationale
The primary goal is endometrial protection. Women with PCOS experience chronic anovulation leading to unopposed estrogen exposure, which significantly increases endometrial hyperplasia and cancer risk 2. The FDA-approved regimen demonstrates that cyclical progesterone (200 mg for 12 days per 28-day cycle) reduces endometrial hyperplasia from 64% (estrogen alone) to only 6% (estrogen plus progesterone) over 3 years 3.
Key Timing Principles
The 12-14 day duration is critical because:
- Minimum 12 days is required for complete secretory transformation of the endometrium 3
- This duration provides adequate endometrial protection against hyperplasia
- Induces predictable withdrawal bleeding, helping women monitor their cycles
- Allows for regular shedding of the endometrial lining
Practical Implementation
For women with irregular or absent cycles:
- Start progesterone on any day and repeat every 28 days (calendar-based approach)
- Alternatively, administer the last 12-14 days of each calendar month
- Withdrawal bleeding typically occurs within 7 days after the last progesterone dose 3
For women using combined oral contraceptives (alternative to cyclic progesterone):
- The progestin component is included daily in the active pills
- This provides continuous endometrial protection
- May be preferred if contraception is also needed 2
Important Caveats
Avoid progestins with anti-androgenic effects in PCOS patients who may already have low testosterone or sexual dysfunction concerns 1. Micronized progesterone is preferred as it has minimal androgenic or anti-androgenic effects.
Weight stigma awareness: When discussing progesterone therapy, focus on metabolic health and endometrial protection rather than weight, as PCOS patients frequently experience weight-related stigma 4.
Monitoring: Women should be counseled that withdrawal bleeding is expected and normal. Absence of bleeding after progesterone withdrawal may indicate inadequate estrogen levels or endometrial issues requiring evaluation 3.
The evidence consistently supports the 12-14 day cyclical regimen as the standard of care for endometrial protection in PCOS patients not seeking pregnancy 1, 3.